Valuation: Haleon plc

Market Cap 28.88B 38.15B 33.88B 31.69B 54.36B 3,673B 55.11B 383B 148B 1,871B 143B 140B 6,008B P/E 2026 *
17x
P/E 2027 * 15.1x
Enterprise Value 35.78B 47.27B 41.98B 39.26B 67.36B 4,551B 68.28B 475B 184B 2,318B 177B 174B 7,444B EV / Sales 2026 *
3.14x
EV / Sales 2027 * 2.97x
Free-Float
98.46%
Yield 2026 *
2.47%
Yield 2027 * 2.72%

Last Transcript: Haleon plc

1 day+0.17%
1 week-4.03%
Current month-2.58%
1 month-10.14%
3 months-8.74%
6 months-11.80%
Current year-12.25%
1 week 324.9
Extreme 324.9
345.4
1 month 324.9
Extreme 324.9
365.43
Current year 317.8
Extreme 317.8
416.1
1 year 317.8
Extreme 317.8
416.1
3 years 274.4
Extreme 274.4
419.5
5 years 241.17
Extreme 241.1735
419.5
10 years 241.17
Extreme 241.1735
419.5
Manager TitleAgeSince
Chief Executive Officer 59 22/07/2021
Director of Finance/CFO 58 01/11/2024
Chief Tech/Sci/R&D Officer 63 01/08/2025
Director TitleAgeSince
Director/Board Member 59 23/05/2022
Chairman 71 01/01/2026
Director/Board Member 59 18/07/2022
Date Insider Type Main position Quantity % Market Cap. Importance
9/22/26 A Buy 2,139 0.0000%
9/22/26 A Buy 12,209 0.0001%
9/22/26 A Buy

Chief Financial Officer

2,317 0.0000%
Change 5-day change 1-year change 3-year change Capi.($)
+0.14%-4.03%-0.24%-2.71% 38.15B
+1.06%-2.38%+40.92%+114.63% 1,025B
-0.42%-5.08%+38.43%+65.94% 623B
+0.03%-1.62%+9.94%+75.43% 459B
-0.05%-3.24%+60.83%+40.38% 355B
-0.87%-3.47%+22.34%+40.21% 336B
-1.37%-2.59%+12.19%+24.99% 270B
-1.01%-4.88%-4.13%+9.04% 247B
-0.58%-1.90%+36.76%+52.72% 220B
-1.10%-2.91%+32.54%+97.76% 183B
Average -0.33%-2.20%+24.96%+51.84% 375.64B
Weighted average by Cap. +0.02%-2.14%+30.84%+69.07%

Financials

2026 *2027 *
Net sales 11.38B 15.04B 13.36B 12.49B 21.43B 1,448B 21.73B 151B 58.5B 737B 56.47B 55.24B 2,369B 11.86B 15.67B 13.92B 13.02B 22.33B 1,509B 22.64B 157B 60.95B 768B 58.83B 57.56B 2,468B
Net income 1.72B 2.28B 2.02B 1.89B 3.25B 219B 3.29B 22.89B 8.86B 112B 8.55B 8.37B 359B 1.93B 2.55B 2.27B 2.12B 3.64B 246B 3.69B 25.64B 9.93B 125B 9.58B 9.37B 402B
Net Debt 6.9B 9.12B 8.1B 7.57B 12.99B 878B 13.17B 91.62B 35.47B 447B 34.23B 33.49B 1,436B 6.3B 8.33B 7.4B 6.92B 11.87B 802B 12.03B 83.7B 32.4B 408B 31.27B 30.59B 1,312B
Logo Haleon plc
Haleon plc specializes in the research, manufacture and marketing of drugs and consumer pharmaceutical products. Net sales break down by family of products as follows: - oral health products (31.4%; no. 1 worldwide): Sensodyne, Parodontax, Polident, Biotene, Aquafresh brands, etc.; - pain relief medicines (23.2%; no. 1 worldwide): Panadol, Advil, Voltaren, Excedrin brands, etc.; - respiratory medicines (17%; no. 1 worldwide): Theraflu, Otrivin, Flonase, Contac brands, etc.; - vitamins, minerals and food supplements (15.3%; no. 1 worldwide): Centrum, Emergen-C, Caltrate brands, etc.; - medicines for digestive health (8.9%; no. 1 worldwide): TUMS, Nicorette, ENO, Chap Stick, Fenistil, Nexium brands, etc.; - other (4.2%). Net sales are distributed geographically as follows: Europe/Middle East/Africa/Latin America (41.6%), North America (35.1%), and Asia/Pacific (23.3%).
Employees
24,535
Date Price Change Volume
02/10/26 GBX 328.80 +0.31% 13,901,754
01/10/26 GBX 327.80 -2.90% 26,596,788
30/09/26 GBX 337.60 +0.15% 35,694,952
29/09/26 GBX 337.10 -0.91% 37,862,405
28/09/26 GBX 340.20 -0.73% 23,909,292
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
3.278GBP
Average target price
4.185GBP
Spread / Average Target
+27.66%

Quarterly revenue - Rate of surprise